ArTCell: Bottom-up manufacturing of artificial anti-tumor T cells
INSTYTUT MEDYCYNY DOSWIADCZALNEJ I KLINICZNEJ IM MIROSLAWA MOSSAKOWSKIEGO POLSKIEJ AKADEMII NAUK
participó en un
HORIZON EUROPE:
HORIZON-EIC-2023-PATHFINDEROPEN-01
T cells play a central role in anti-tumor immune protection. While their ability to target and eliminate emerging tumor cells is increasingl...
2023-10-09 - 2029-01-31 | Financiado
2023-10-09 - 2029-01-31 | Financiado
STIMUNO: Searching for novel strategies improving cancer immunotherapy
INSTYTUT MEDYCYNY DOSWIADCZALNEJ I KLINICZNEJ IM MIROSLAWA MOSSAKOWSKIEGO POLSKIEJ AKADEMII NAUK
tramitó un
H2020:
ERC-2018-STG
The main goal of this project is to explore new fundamental pathways involved in the regulation of antitumor immune response. Since the immu...
2018-10-10 - 2025-02-28 | Financiado
2018-10-10 - 2025-02-28 | Financiado
Proteasome in cancer: Identification of the proteasome machinery targets in human cancer
INSTYTUT MEDYCYNY DOSWIADCZALNEJ I KLINICZNEJ IM MIROSLAWA MOSSAKOWSKIEGO POLSKIEJ AKADEMII NAUK
tramitó un
H2020:
H2020-MSCA-IF-2017
The 26S/20S proteasome and immunoproteasome machinery is the major protein degradation system in human cells and a strongly oncogenic factor...
2018-04-09 - 2020-04-30 | Financiado
2018-04-09 - 2020-04-30 | Financiado
* No se disponen de datos de la empresa actual.